Advances in immunotherapy for MMR proficient colorectal cancer

Lote, H; Starling, N; Pihlak, R; Gerlinger, M

Gerlinger, M (通讯作者)，Barts Canc Inst, Charterhouse Sq, London EC1M 5PZ, England.

CANCER TREATMENT REVIEWS, 2022; 111 ():

Abstract

Survival in mismatch-repair proficient (MMRp) metastatic colorectal cancer (mCRC) remains poor and chemotherapy is the mainstay of treatment. Immunoth......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索